Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical development. Its structure supports the formation of constrained peptidomimetics, making it valuable in drug design for enhancing metabolic stability and binding affinity. Commonly employed in the preparation of protease inhibitors and other therapeutic agents targeting central nervous system disorders. The sulfonamide and carbamate functionalities allow for selective modifications, facilitating optimization of pharmacokinetic properties in lead compounds.